Saitama, Japan

Tomohiko Ishikawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fuji Yakuhin Co., Ltd. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiko Ishikawa. Retrieved from https://idiyas.com/inventor/tomohiko-ishikawa-ghi9etmk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohiko Ishikawa: Innovator in Medicinal Chemistry

Introduction

Tomohiko Ishikawa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on phenylacetic acid derivatives. His research focuses on developing compounds that can effectively suppress the production of prostaglandin E, which is crucial for creating medications with fewer adverse reactions.

Latest Patents

Ishikawa holds a patent for a phenylacetic acid derivative, which is represented by a complex chemical formula. This compound, or its salt, exhibits a superior suppressing action against prostaglandin E production. It is particularly useful as an active ingredient in medicaments that aim to minimize gastrointestinal disorders and other side effects.

Career Highlights

Ishikawa is currently associated with Fuji Yakuhin Co., Ltd., where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that enhance patient safety and efficacy.

Collaborations

Throughout his career, Ishikawa has collaborated with esteemed colleagues such as Hideo Kato and Osamu Nagata. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Tomohiko Ishikawa's contributions to medicinal chemistry highlight the importance of innovation in developing safer and more effective medications. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…